A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
14-3-3 eta Protein [91455]
MessageFor Specimen Integrity during Extreme Weather see the “Lockbox Usage in Extreme Weather” document at the top of this page.
Test Code
1433PR
Alias/See Also
91455
CPT Codes
83520
Preferred Specimen
1 mL serum
Minimum Volume
0.5 mL
Instructions
Allow blood to clot (10-15 minutes) at room temperature. Centrifuge and
separate from cells. Ship refrigerated.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Referigerated: 7 days
Frozen: 21 days
Referigerated: 7 days
Frozen: 21 days
Methodology
Enzyme Linked Immunosorbent Assay (ELISA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon, Wed, Sat; Report available: 4-8 days
Reference Range
<0.2 ng/mL
Clinical Significance
14-3-3 eta protein is released into the circulation as part of the pathological process of joint inflammation and joint erosion in rheumatoid arthritis (RA) and psoriatic arthritis. Concentrations are significantly higher in people with active joint disease than in those with inactive RA or psoriasis without arthritis. An elevated 14-3-3 eta level supports the diagnosis of RA and can help predict disease severity.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
33608 Ortega Highway |
San Juan Capistrano, CA 92675-2042 |
Last Updated: December 7, 2021